Overview of Randomized Controlled Treatment Trials for Clinically Localized Prostate Cancer: Implications for Active Surveillance and the United States Preventative Task Force Report on Screening?-Reference-Cited by-同舟云学术

Overview of Randomized Controlled Treatment Trials for Clinically Localized Prostate Cancer: Implications for Active Surveillance and the United States Preventative Task Force Report on Screening?

Published:2012-12-01 Issue:45 Volume:2012 Page:221-229
ISSN:1052-6773
Container-title:JNCI Monographs
language:en
Short-container-title:JNCI Monographs

Author:

Roach M.,Thomas K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology,General Medicine

Link

http://academic.oup.com/jncimono/article-pdf/2012/45/221/2839755/lgs039.pdf

Reference70 articles.

1. The number needed to treat: a clinically useful measure of treatment effect

2. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

3. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

4. Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

5. CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed definitive management of localized prostate cancer: what do we know?;Prostate Cancer and Prostatic Diseases;2024-08-11

2. Age 70 +/– 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review;International Journal of Radiation Oncology*Biology*Physics;2023-10

3. Radiation Delay Is Okay, but Where Is the Evidence?;JAMA Oncology;2021-03-01

4. Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance;European Urology Open Science;2021-01

5. PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes;Journal of the National Comprehensive Cancer Network;2019-07